Corporate Finance Enters a Golden Age as AI and Autonomous Agents Redefine the Office of the CFO

Corporate Finance Enters a Golden Age as AI and Autonomous Agents Redefine the Office of the CFO Auditoria's sixth annual State of AI Automation in the Finance Office Report reveals rising adoption of generative AI and autonomous agents, but persistent bottlenecks in document extraction and shared inboxes continue to slow progress GlobeNewswire October 29, 2025 […]

Acronis Announces Cyber Protect Local to Deliver Unified Cyber Resilience for On-Premises and Sovereign IT/OT Environments

Acronis Announces Cyber Protect Local to Deliver Unified Cyber Resilience for On-Premises and Sovereign IT/OT Environments All-in-one cyber protection empowers organizations with proven backup, security, and support for legacy-to-modern infrastructures GlobeNewswire October 29, 2025 SCHAFFHAUSEN, Switzerland, Oct. 29, 2025 (GLOBE NEWSWIRE) — Acronis, a global leader in cybersecurity and data protection, today announced the launch

Dave Appoints Parker Barrile as Chief Product Officer

Dave Appoints Parker Barrile as Chief Product Officer Veteran Product Leader Will Help Drive Next Phase of Dave's Growth and Further Strengthen Its Position as a Leader in Fintech GlobeNewswire October 29, 2025 Los Angeles, Oct. 29, 2025 (GLOBE NEWSWIRE) — Dave Inc. (“Dave” or the “Company”) (Nasdaq: DAVE), one of the nation's leading neobanks,

Capital Power reports strong third quarter 2025 results, advancing flexible generation(1) growth and contracting success

Capital Power reports strong third quarter 2025 results, advancing flexible generation(1) growth and contracting success CFO Sandra Haskins announces retirement after 23 years of leadership and financial excellence GlobeNewswire October 29, 2025 EDMONTON, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) today released financial results for the quarter ended September 30,

CHAR Tech Invited to Join the Canadian Iron & Steel Energy Research Association (CISERA)

CHAR Tech Invited to Join the Canadian Iron & Steel Energy Research Association (CISERA) GlobeNewswire October 29, 2025 TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) — CHAR Technologies Ltd. (“CHAR Tech” or the “Company“) (TSXV:YES), a leader in sustainable energy solutions, is pleased to announce that it has been invited to join the Canadian Iron &

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Quantum Corporation (QMCO), Tronox Holdings plc (TROX), Fly-E Group, Inc. (FLYE), and Savara Inc. (SVRA)

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Quantum Corporation (QMCO), Tronox Holdings plc (TROX), Fly-E Group, Inc. (FLYE), and Savara Inc. (SVRA) GlobeNewswire October 29, 2025 ATLANTA, Oct. 29, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to

Teads appoints Fernando Tassinari as Managing Director of LATAM to lead a new phase of regional growth and transformation

Teads appoints Fernando Tassinari as Managing Director of LATAM to lead a new phase of regional growth and transformation GlobeNewswire October 29, 2025 SÃO PAULO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Teads (NASDAQ: TEAD), the omnichannel outcomes platform for the Open Internet, today announced the appointment of Fernando Tassinari as Managing Director of LATAM, effective

Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules GlobeNewswire October 29, 2025 SAN RAFAEL, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that on October 28, 2025, it

OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications

OPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications GlobeNewswire October 29, 2025 Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance WESTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) — ModeX

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of MoonLake Immunotherapeutics (MLTX) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of MoonLake Immunotherapeutics (MLTX) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm GlobeNewswire October 29, 2025 ATLANTA, Oct. 29, 2025 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX).

Scroll to Top